Selective suppression of humoral immunity by antineoplastic drugs.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001665:Binding Sites / Q000187:drug effects; D002645:Chickens; D003520:Cyclophosphamide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D005472:Fluorouracil / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D002955:Leucovorin / Q000494:pharmacology; D008297:Male; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D009369:Neoplasms / Q000276:immunology; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D010879:Piperazines; D003561:Cytarabine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate